Clinical observation of the effect of Xuesaitong soft capsule on post-hepatitis fibrosis.
- Author:
Yin-quan DENG
1
;
Xiao-fen FAN
;
You-di LI
Author Information
- Publication Type:Clinical Trial
- MeSH: Adult; Capsules; Drugs, Chinese Herbal; administration & dosage; adverse effects; therapeutic use; Female; Hepatitis B, Chronic; complications; Humans; Liver; physiopathology; Liver Cirrhosis; drug therapy; pathology; physiopathology; virology; Male; Middle Aged; Treatment Outcome
- From:Chinese journal of integrative medicine 2005;11(1):11-14
- CountryChina
- Language:English
-
Abstract:
OBJECTIVETo study the effect of Xuesaitong soft capsule (XST) on liver fibrosis criteria in patients with post-hepatitis fibrosis.
METHODSSixty-four patients with such fibrosis were randomly divided into the treated group and control group. They were treated with XST and Dahuang Zhechong pill (NFDA1) for 3 months respectively. Their liver fibrosis criteria were examined before and after treatment.
RESULTSThe levels of serum procollagen III, hyaluronic acid, collagen IV, laminin in the two groups were significantly lower (P < 0.01) than those before treatment. The differences between the two groups were insignificant (P > 0.05).
CONCLUSIONXST could recover liver dysfunction and had anti-liver fibrosis function.
